Continuous-infusion beta-lactam antibiotics during continuous venovenous hemofiltration for the treatment of resistant gram-negative bacteria.

Moriyama, Brad; Henning, Stacey A; Neuhauser, Melinda M; Danner, Robert L; Walsh, Thomas J

Moriyama, Brad; Henning, Stacey A; Neuhauser, Melinda M; Danner, Robert L; Walsh, Thomas J.

Affiliation

Moriyama B; Pharmacy Department, National Institutes of Health Clinical Center, Bethesda, MD, USA.

Ann Pharmacother ; 43(7): 1324-37, 2009 Jul.

Article in En | MEDLINE | ID: mdl-19584386

Subject(s)

Anti-Bacterial Agents/administration & dosage; Gram-Negative Bacterial Infections/drug therapy; Hemofiltration; beta-Lactams/administration & dosage; Animals; Anti-Bacterial Agents/adverse effects; Anti-Bacterial Agents/pharmacokinetics; Clinical Trials as Topic; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria/drug effects; Gram-Negative Bacterial Infections/microbiology; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; beta-Lactams/adverse effects; beta-Lactams/pharmacokinetics

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Hemofiltration / Gram-Negative Bacterial Infections / Beta-Lactams / Anti-Bacterial Agents Language: En Journal: Ann Pharmacother Year: 2009 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google